SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after securing a $250 million capital commitment that extends its operational runway to 2028, fueling community debate between those anticipating a major short squeeze as the company shifts to revenue generation, and others worried about continued dilution and fundamental value.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is rallying after a strong earnings report showcased impressive user and subscriber growth alongside improved profitability and optimistic guidance, prompting analyst upgrades and expectations for higher price targets. The community is actively discussing these strategic gains, even as debate continues around recent subscription price increases and competition in the streaming sector.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as investors debate its post-earnings performance, with bulls highlighting the stock's perceived undervaluation at a low single-digit forward P/E and new management's turnaround strategy, while bears express concern over declining margins, debt, and broader fintech sector headwinds. The community is actively discussing a potential short squeeze against the backdrop of significant institutional buying and recent board appointments.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is a major talking point as Infleqtion, its quantum technology merger target, recently secured a NASA space mission role and a significant U.S. Department of Energy contract, leading many to believe it's severely undervalued compared to other quantum stocks ahead of its anticipated merger and ticker change to INFQ.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies trends after an earnings report revealed strong revenue and GMV growth, significant cash burn reduction, and a clear path to profitability without needing a capital raise, yet the stock's initial dip has puzzled many long-term investors who view it as the "Amazon of Africa" for an underserved market.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending after reporting strong 52-week maintenance data for its atopic dermatitis drug, rezpegaldesleukin, demonstrating durable efficacy comparable to or exceeding competitors like Dupixent. The community is buzzing about the drug's potential, with many anticipating higher price targets, a significant short squeeze, and the possibility of a big pharma buyout.

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Evommune Inc.

Evommune Inc

Evommune is seeing a surge in attention after announcing positive Phase 2a trial results for its atopic dermatitis drug EVO301, sparking a battle between bullish traders anticipating a short squeeze and a skeptical community betting against the rally amid claims of overvaluation.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is generating buzz following its latest earnings report, where a substantial 2026 guidance predicting profitability and record membership growth is fueling a bullish narrative. This optimism directly contrasts with a quarterly financial miss that has skeptics questioning the sustainability of its aggressive forward outlook amidst broader healthcare sector uncertainties.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending after reporting strong Q4 earnings that initially sent the stock higher, driven by significant client additions and an upbeat outlook. However, these gains were quickly erased as concerns over increased competition in the observability sector, including recent acquisitions by rivals, are actively weighing on community sentiment.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following an "Overweight" rating from a major investment bank, highlighting its strong data center deals and power infrastructure expertise. The community is buzzing about the potential for a short squeeze and the company's critical role in the expanding AI infrastructure, with many viewing it as a prime beneficiary of hyperscaler capital expenditures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

Here is how ALX Oncology Holdings Inc. (ALXO) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.

Insider Buying: ALX Oncology (NASDAQ:ALXO) Director Purchases $4,999,999.41 in Stock

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) Director Corey Goodman bought 3,184,713 shares of ALX Oncology stock in a transaction that occurred on Monday, February 2nd. The stock was...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the firm, Marketbeat reports...

ALX Oncology Spotlights Evorpacept HER2 Strategy and EGFR ADC ALX2004 Progress at JPM Conference

ALX Oncology (NASDAQ:ALXO) outlined progress across its two clinical-stage programs CD47 blocker evorpacept and EGFR-targeted antibody-drug conjugate (ADC) ALX2004 during a presentation at the J.P...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat...

Short Interest in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Expands By 32.0%

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,047,613 shares...

ALX Oncology (NASDAQ:ALXO) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised shares of ALX Oncology from a "sell" rating to a "hold" rating in a research report on Monday...

ALX Oncology (NASDAQ:ALXO) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded shares of ALX Oncology from a "hold" rating to a "sell" rating in a research report on Sunday...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of "Moderate Buy" from Analysts

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat.com...

ALX Oncology (NASDAQ:ALXO) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded ALX Oncology from a "sell" rating to a "hold" rating in a report on Saturday...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

Alx Oncology Holdings Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $SHOP earnings on Wednesday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.36	--	--	N/A
Q3 '25	-$0.37	-$0.41	-11.82%	MISSED
Q2 '25	-$0.42	-$0.49	-16.12%	MISSED
Q1 '25	-$0.46	-$0.58	-25.05%	MISSED
Q4 '24	-$0.67	-$0.55	17.91%	BEAT

ALXO
Alx Oncology Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ALXO News

ALXOAlx Oncology Holdings Inc